Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2146553 | Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis | 2011 | 7 Pages |
Abstract
MicroRNAs (miRs) are short RNA chains that regulate gene expression by inhibition of mRNA translation. Their expression is often deranged in cancer. Increasing evidence indicates that these molecules play an important role in oncogenesis and cancer progression. This review focuses on the clinical application of miRs in lung cancer, with the emphasis on detection of early lung cancer, prognostication and chemotherapy sensitivity prediction. Methodological aspects of studies on prognostic markers in early NSCLC are outlined in detail. Finally, modulation of miR expression in lung cancer as a therapeutic possibility is discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Marcin Skrzypski, Rafał Dziadziuszko, Jacek Jassem,